On behalf of Pivot, Thrudermic recently filed three additional patent applications related to improved formulation and delivery for new routes of administration of cannabinoids and will increase the number of products in the Company’s pipeline. “Thrudermic is very excited to become part of the Pivot … Read More
The post Pivot Pharma Acquires Thrudermic, LLC appeared first on Dagga Magazine.